See more : Medicalsystem Biotechnology Co., Ltd. (300439.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Polaris Group (6550.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Polaris Group, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Japan Pure Chemical Co., Ltd. (4973.T) Income Statement Analysis – Financial Results
- Sarvottam Finvest Limited (SARVOTTAM.BO) Income Statement Analysis – Financial Results
- HighGold Mining Inc. (HIGH.V) Income Statement Analysis – Financial Results
- Hellenic Telecommunications Organization S.A. (HLTOF) Income Statement Analysis – Financial Results
- Proton Motor Power Systems Plc (PPS.L) Income Statement Analysis – Financial Results
Polaris Group (6550.TW)
About Polaris Group
Polaris Group, together with its subsidiaries, operates as a consulting company. The company provides healthcare consulting; staffing solutions; and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.48M | 6.44M | 15.04M | 9.41M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 145.38M | 148.30M | 165.66M | 140.19M | 138.35M | 110.51M | 113.79M | 128.14M |
| Gross Profit | -137.90M | -141.86M | -150.62M | -130.78M | -138.35M | -110.51M | -113.79M | -128.14M |
| Gross Profit Ratio | -1,843.35% | -2,203.15% | -1,001.40% | -1,389.83% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.54B | 923.97M | 554.29M | 545.22M | 633.09M | 785.90M | 615.87M | 697.84M |
| General & Administrative | 307.28M | 234.99M | 179.72M | 135.27M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -134.84M | -143.28M | -152.72M | -133.27M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 172.45M | 91.72M | 27.01M | 1.99M | 23.78M | 117.30M | 114.08M | 122.19M |
| Other Expenses | 0.00 | -32.29M | 8.19M | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -3.07M | 1.02B | 581.30M | 547.22M | 656.87M | 903.20M | 729.95M | 820.03M |
| Cost & Expenses | 1.85B | 1.16B | 746.96M | 687.41M | 795.22M | 1.01B | 843.74M | 948.17M |
| Interest Income | 303.55M | 64.74M | 7.89M | 27.06M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 32.59M | 11.05M | 14.67M | 5.16M | 0.00 | 44.85M | 55.61M | 50.27M |
| Depreciation & Amortization | 135.38M | 143.72M | 154.07M | 133.27M | 138.35M | 110.51M | 113.79M | 128.14M |
| EBITDA | -1.41B | -981.38M | -570.97M | -516.08M | -655.10M | -886.71M | -738.57M | -801.89M |
| EBITDA Ratio | -18,828.20% | -15,745.18% | -3,841.82% | -5,788.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.85B | -1.16B | -731.92M | -678.00M | -795.22M | -1.01B | -843.74M | -948.17M |
| Operating Income Ratio | -24,689.84% | -17,977.12% | -4,866.15% | -7,205.08% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 289.58M | 21.40M | -7.79M | 23.49M | -33.72M | -18.51M | -53.63M | -32.13M |
| Income Before Tax | -1.56B | -1.14B | -730.51M | -654.51M | -828.94M | -1.03B | -897.37M | -980.30M |
| Income Before Tax Ratio | -20,818.98% | -17,644.73% | -4,856.78% | -6,955.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 15.55M | 5.53M | 777.00K | 48.00K | 820.00K | 47.00K | 1.08M | 2.16M |
| Net Income | -1.58B | -1.15B | -740.49M | -660.22M | -829.76M | -1.03B | -898.45M | -982.46M |
| Net Income Ratio | -21,075.98% | -17,866.64% | -4,923.12% | -7,016.20% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -2.12 | -1.57 | -1.09 | -1.01 | -2.46 | -3.58 | -3.60 | -4.14 |
| EPS Diluted | -2.12 | -1.57 | -1.09 | -1.01 | -2.46 | -3.58 | -3.60 | -4.14 |
| Weighted Avg Shares Out | 743.65M | 732.61M | 680.10M | 652.90M | 336.80M | 288.54M | 249.32M | 237.31M |
| Weighted Avg Shares Out (Dil) | 743.65M | 732.61M | 680.10M | 652.90M | 336.80M | 288.54M | 249.32M | 237.31M |
No news found for: 6550.TW
Source: https://incomestatements.info
Category: Stock Reports